A Th1-Th2 drift will lead to immunosuppression and cancer development (16).Therefore, when IL-5 levels are high during immunotherapy, the differentiation and growth of B cells are correspondingly promoted, thus increasing the secretion of antibodies, leading to the over activated humoral immune response which may attack normal tissues and organs of the body. The gene discussed is IL5; the disease is cancer.